Ab Tomenterprise - Net Worth and Insider Trading
Ab Tomenterprise Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ab Tomenterprise owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .
Click here to see the complete history of Ab Tomenterprise’s form 4 insider trades.
Insider Ownership Summary of Ab Tomenterprise
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DMAC | DiaMedica Therapeutics Inc | 2023-06-23 | 10 percent owner |
Ab Tomenterprise Trading Performance
Ab Tomenterprise Ownership Network
Ab Tomenterprise Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Ab Tomenterprise is the 10 percent owner of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include 10 percent owner Koch Thomas Von , 10 percent owner Jan Stahlberg , and CFO and Secretary Scott Kellen .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Ab Tomenterprise made no insider transaction in DiaMedica Therapeutics Inc (DMAC). Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 1,200,000 shares made by Jan Stahlberg , a net purchase of 1,200,000 shares made by Koch Thomas Von , and a net purchase of 20,000 shares made by David J. Wambeke .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 2,420,000 shares were bought by its insiders, resulting in a net purchase of 2,420,000 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Ab Tomenterprise Mailing Address
Above is the net worth, insider trading, and ownership report for Ab Tomenterprise. You might contact Ab Tomenterprise via mailing address: C/o Eqt Partners Ab, Box 16509, Stockholm V7 103 27.